Acute congestive heart failure and tumor necrosis factor alpha

American Journal of Geriatric Cardiology

Volumn 9, Issue 2, 2000, Pages 76-80

  Somasundaram, P ^a   Sung, B H ^a   Mousa, S A ^a   Wilson, M F ^a  

^a MILLARD FILLMORE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; AGED; AGING; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DETERIORATION; DISEASE EXACERBATION; DISEASE MARKER; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG EDEMA; MALE; PROTEIN BLOOD LEVEL;

EID: 0033841674     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2000.80012.x     Document Type: Article

References (14)

1. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
2. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?
3. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
4. Tumor necrosis factor-alpha and the failing human heart
5. Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure
6. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
7. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
8. Tumor necrosis factor alpha in severe congestive cardiac failure
9. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart
10. The importance of cachexia in the syndrome of heart failure
11. Infusion of tumor necrosis factor/cachectin produces muscle catabolism in the rat: Asynergistic effect with interleukin-I
12. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
13. Tumor necrosis factor in the heart
14. A phase I trial of tumor necrosis factor receptor fusion protein (TNPR:Fc) in patients with advanced heart